Comparison of the Safety, Efficacy and Pharmacokinetics of DehydraTECH -CBD and DehydraTECH-GLP1 Agonists Alone or in Combination, in Overweight or Obese, Pre- and Type 2 Diabetic Participants

计划入组 148 人 · 首次发布于 2024 年 10 月 18 日

Senicapoc and Dehydrated Stomatocytosis

计划入组 5 人 · 首次发布于 2020 年 5 月 4 日

TARGET BP I Clinical Trial

计划入组 300 人 · 首次发布于 2016 年 9 月 22 日

DehydraTECH-Antiviral

DehydraTECH-PDE5

Dehydrated Alcohol Injection (Eton Pharmaceuticals)

Lexaria Bioscience

United States

Lexaria's DehydraTECH Technology Enhances Semaglutide Brain Delivery in Preclinical Study

Lexaria Bioscience Advances DehydraTECH Platform to Enhance GLP-1 Drug Effectiveness

Lexaria Bioscience Receives FDA Clearance for Phase 1b Hypertension Trial of DehydraTECH-CBD